To validate the inhibitory effect of the AKT inhibitor on SOX2 protein levels, we treated SOX2-positive osteosarcoma (OS) cell lines, specifically HOS, with the AKT inhibitor MK2206 at varying concentrations for 24 h. The gene discussed is AKT1; the disease is osteosarcoma.